Myosin 9 Antikörper (pSer1943)
Kurzübersicht für Myosin 9 Antikörper (pSer1943) (ABIN7464174)
Target
Alle Myosin 9 (MYH9) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- pSer1943
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Affinity purified by Protein G.
-
Immunogen
- Carrier-protein conjugated synthetic peptide surrounding phospho Ser1943 of human MYH9. The exact sequence is proprietary.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB: 1:5000-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Positive Control: 293T , A431 , HeLa , HepG2
Validation: KO/KD, Orthogonal
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, No Preservative
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Myosin 9 (MYH9)
-
Andere Bezeichnung
- myosin heavy chain 9
-
Hintergrund
- Myosin heavy chain 9 , BDPLT6 , DFNA17 , EPSTS , FTNS , MATINS , MHA , NMHC-II-A , NMMHC-IIA , NMMHCA,This gene encodes a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq]
-
Molekulargewicht
- 227 kDa
-
Gen-ID
- 4627
-
UniProt
- P35579
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex
Target
-